Critical Review: Evolus (NASDAQ:EOLS) & Futureworld (OTCMKTS:FWDG)

Evolus (NASDAQ:EOLSGet Free Report) and Futureworld (OTCMKTS:FWDGGet Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, valuation, profitability, analyst recommendations, earnings, institutional ownership and dividends.

Institutional and Insider Ownership

90.7% of Evolus shares are owned by institutional investors. 5.0% of Evolus shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Evolus and Futureworld, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evolus 1 1 4 0 2.50
Futureworld 0 0 0 0 0.00

Evolus currently has a consensus price target of $16.00, suggesting a potential upside of 136.16%. Given Evolus’ stronger consensus rating and higher probable upside, research analysts clearly believe Evolus is more favorable than Futureworld.

Earnings and Valuation

This table compares Evolus and Futureworld”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Evolus $301.79 million 1.48 -$51.64 million ($0.67) -10.11
Futureworld N/A N/A N/A N/A N/A

Futureworld has lower revenue, but higher earnings than Evolus.

Volatility and Risk

Evolus has a beta of 1.34, indicating that its stock price is 34% more volatile than the S&P 500. Comparatively, Futureworld has a beta of -0.12, indicating that its stock price is 112% less volatile than the S&P 500.

Profitability

This table compares Evolus and Futureworld’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Evolus -14.39% N/A -19.03%
Futureworld N/A N/A N/A

Summary

Evolus beats Futureworld on 7 of the 9 factors compared between the two stocks.

About Evolus

(Get Free Report)

Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

About Futureworld

(Get Free Report)

FutureWorld Corp., together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of hemp/cannabis products, services, and technologies worldwide. The company provides smart sensor technology, communication network, surveillance security, data analysis for smart cultivation, and consultation for the industrial hemp and legal medicinal marijuana. It offers personal and professional tetrahydrocannabinoil and Cannabidiol test kits; pharmaceutical grade CBD oil solutions; URVape vaporizer pens, which are oil vaporizers for the e-cigarette, cannabis, and herbal vaping industry; CaNNaLyTiX, a dashboard controller system that allows various computer systems to be integrated throughout a cultivator's infrastructures; CaNNaTRAK, the barcode and RFID tracking systems for keeping seed to sale tracking of hemp/cannabis; and SPIDer (secure perimeter intrusion detection network), a system to meet the needs of theft and malicious attacks. The company also provides SmartSense, which offers wireless security and smart sensor mesh network for precision agriculture, irrigation systems, and greenhouses for the hemp industry; SmartNergy that offers tools to analyze various aspects of a cultivator's energy usage; and CaNNaBoX machine, which operates with the swipe of a card to verify identity, age, and prescription information of a medical marijuana patient before releasing measured packages of marijuana. Its target customers include consumers via Internet sales, direct-to-consumer health and wellness stores, collectives, cooperatives, affiliate sales, and master distributors. The company was formerly known as FutureWorld Energy, Inc. and changed its name to FutureWorld Corp. in June 2014. FutureWorld Corp. was founded in 2002 and is based in Saint Petersburg, Florida.

Receive News & Ratings for Evolus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolus and related companies with MarketBeat.com's FREE daily email newsletter.